Last update:

Parkinson's & Movement disorders news

Medications

How gut bacteria affect the treatment of Parkinson's disease

Patients with Parkinson's disease are treated with levodopa, which is converted into dopamine, a neurotransmitter in the brain. In a study published on 18 January in the journal Nature Communications, scientists from the ...

Parkinson's & Movement disorders

FDA approves scalpel-free treatment for Parkinson's disease tremor

The federal Food and Drug Administration has approved a new, scalpel-free treatment for tremor in patients with medication-resistant Parkinson's disease.

Parkinson's & Movement disorders

Defective glial cells can push neurons toward Parkinson's disease

Researchers from the University of Barcelona have shown that defective versions of human brain cells called astrocytes are linked to the buildup of a toxic protein that is the hallmark of Parkinson's disease. The studied ...

Parkinson's & Movement disorders

Scientists uncover how protein clumps damage cells in Parkinson's

Biologists studying Parkinson's disease have long hoped to solve the mystery of the telltale "clumps." Scientists want to know how clumps of misfolded proteins damage brain cells and contribute to the disease.

Parkinson's & Movement disorders

Parkinson's disease experts devise a roadmap

A recently discovered protein, alpha-synuclein, has become one of the most attractive targets for developing new drugs with the potential to slow down or arrest the progression of Parkinson's disease (PD). Experts in the ...

Parkinson's & Movement disorders

Two compounds in coffee may team up to fight Parkinson's

Rutgers scientists have found a compound in coffee that may team up with caffeine to fight Parkinson's disease and Lewy body dementia—two progressive and currently incurable diseases associated with brain degeneration.

Parkinson's & Movement disorders

A toxin that travels from stomach to brain may trigger Parkinsonism

Combining low doses of a toxic herbicide with sugar-binding proteins called lectins may trigger Parkinsonism—symptoms typical of Parkinson's disease like body tremors and slowing of body motions—after the toxin travels ...

Parkinson's & Movement disorders

Experimental cancer drug shows promise for Parkinson's

The study, funded by Parkinson's UK, suggests that the drug, tasquinimod, which is not yet on the market, works by controlling genes that may cause Parkinson's. This happens when the drug interacts with a protein inside brain ...

Parkinson's & Movement disorders

Scientists overturn odds to make Parkinson's discovery

Scientists at the University of Dundee have confirmed that a key cellular pathway that protects the brain from damage is disrupted in Parkinson's patients, raising the possibility of new treatments for the disease.